Adma Biologics ADMA
NASDAQ ADMA
$9.56 -0.02 (-0.16%)
As of: Sep 4, 2026 · 2:26 PM EDT

Adma Biologics (ADMA) Preferred Shares (2011 - 2020)

Adma Biologics' (ADMA) quarterly Preferred Shares came in at $8222.0 in Q4 2011.

Analysis

Adma Biologics (ADMA) Preferred Shares (2011 - 2020) Analysis & Trends

Adma Biologics (ADMA) has 1 years of Preferred Shares data on file, last reported at $8222.0 in Q4 2011.

  • Quarterly Preferred Shares changed N/A year-over-year to $8222.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $8222.0 (changed N/A YoY) and the FY2011 annual result came in at $8222.0, changed N/A from the prior year.
  • Preferred Shares steadied at $8222.0 in Q4 2011.
  • In the past five years, Preferred Shares ranged from a high of $8222.0 in Q4 2011 to a low of $8222.0 in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -
5 Revolution Medicines 44.07 Bn 44.07 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -
10 Adma Biologics 2.18 Bn 2.05 Bn 86.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 10.00 Mn
Dec 31, 2019 10.00 Mn
Dec 31, 2011 8,222.00